ROCKWELL MEDICAL, INC.
About ROCKWELL MEDICAL, INC.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$5.3M
- Total assets
- $57.1M
- Market cap
- $26.2M
- Gross margin
- 16.9%
- Operating margin
- -6.8%
- Net margin
- -7.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $69.3M
- Cost of revenue
- $57.6M
- Gross profit
- $11.7M
- Operating expenses
- $16.4M
- Operating income
- -$4.7M
- Income tax
- $0
- Net income
- -$5.3M
- EPS (basic)
- $-0.15
- EPS (diluted)
- $-0.15
Balance sheet
- Total assets
- $57.1M
- Current assets
- $38.2M
- Total liabilities
- $20.2M
- Current liabilities
- $9.6M
- Shareholders’ equity
- $37.0M
Cash flow
- Operating cash flow
- -$659.0K
- Investing cash flow
- -$8.5M
- Financing cash flow
- $4.3M
- Net cash flow
- -$5.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $26.2M
- EPS (diluted)
- $-0.15
- Shares outstanding
- 39.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 27, 1998
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $5.3M.
- Revenue grew 12% from FY2021 to FY2025.
- Gross margin of 16.9%, net margin -7.7%.
- Trading 64% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ROCKWELL MEDICAL, INC..
Write a review
News about ROCKWELL MEDICAL, INC.
News & sentiment via Polygon.io
